Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Jones

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2009
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myelomaUday Popat, Rima Saliba, Rupinderjit Thandi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 1, 2020
Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipientsAla Abudayyeh, Heather Lin, Maen Abdelrahim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomasIssa F Khouri, Rima M Saliba, Chitra Hosing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2015
Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological MalignanciesAmin M Alousi, Jonathan E Brammer, Rima M Saliba, et al.
Journal of Psychopharmacology (Oxford, England)|October 25, 2006
Clinical practice with anti-dementia drugs: a consensus statement from British Association for PsychopharmacologyAlistair Burns, John O'Brien, , et al.
Journal of Alzheimer'S Disease : JAD|February 18, 2009
Methodological issues in primary prevention trials for neurodegenerative dementiaSandrine Andrieu, Nicola Coley, Paul Aisen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 28, 2016
Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe PancytopeniaFleur M Aung, Benjamin Lichtiger, Gabriela Rondon, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 31, 2013
The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantationRohtesh S Mehta, Antonio Di Stasi, Borje S Andersson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2020
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical TrialUday Popat, Rohtesh S Mehta, Roland Bassett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2013
A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myelomaQaiser Bashir, Hassan Khan, Peter F Thall, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2009
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myelomaUday Popat, Rima Saliba, Rupinderjit Thandi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 1, 2020
Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipientsAla Abudayyeh, Heather Lin, Maen Abdelrahim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomasIssa F Khouri, Rima M Saliba, Chitra Hosing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2015
Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological MalignanciesAmin M Alousi, Jonathan E Brammer, Rima M Saliba, et al.
Journal of Psychopharmacology (Oxford, England)|October 25, 2006
Clinical practice with anti-dementia drugs: a consensus statement from British Association for PsychopharmacologyAlistair Burns, John O'Brien, , et al.
Journal of Alzheimer'S Disease : JAD|February 18, 2009
Methodological issues in primary prevention trials for neurodegenerative dementiaSandrine Andrieu, Nicola Coley, Paul Aisen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 28, 2016
Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe PancytopeniaFleur M Aung, Benjamin Lichtiger, Gabriela Rondon, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 31, 2013
The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantationRohtesh S Mehta, Antonio Di Stasi, Borje S Andersson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2020
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical TrialUday Popat, Rohtesh S Mehta, Roland Bassett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2013
A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myelomaQaiser Bashir, Hassan Khan, Peter F Thall, et al.
Pageof 9